who is this guy?, page-2

Hi fazz03

"who is this guy?"

Someone with mates at Deutsche Bank, Noble or Aegis, maybe?

He uses a nice play on words... I'll give him credit for that...
___

"Since then, the high performing biotech's stock has fallen about 15 per cent. This is possibly a portent of more to come."

Since 2009, the high performing biotech's stock has risen about + 4,300%. Since its 2010 low, + 168%. Some might also argue that this is "a portent of more to come"
___

"The clinical results Prima Biomed has come up with so far do not seem to support its share price rise from 2¢ or so in early 2009, to peak at 39¢ this time last year."

The clinical results Prima Biomed has come up with so far, "exceeded expectations" so perhaps its share price rise from 2c $0.005c or so in early 2009 was reflective of this combined with seeing the bottom of a GFC.

Note: Dendreon Market Cap
2007 = $500m
2009 = $600m
___

"The full results of its preliminary (phase two) are due out in the next few months, but what we know so far is that the data from 21 patients "has not demonstrated statistically significant results", in the words of a report by Nomura Equity Research."

In the words of the Principal Investigator, Prof Paul Mitchell, Director Cancer Services:
“despite the advanced stage of disease this new product candidate clearly showed benefit in a statistically significant number of these patients.”
___

"Prima works with the new breed of "biologic" drugs, made from cell lines that are almost impossible to copy, rather than the simple chemical synthesis used to develop small molecule drugs such as aspirin"

Aspirin was developed in 1853 for minor indications - Not for treating Ovarian Cancer. Prima is focusing on major markets with unmet medical needs - Cell Therapy! A new paradigm for the treatment of cancer in the 21st Century.
___

"One of the most successful biotechs is Sirtex Medical, which recently announced sales for its liver cancer treatment increased 34 per cent for the third quarter. That's right, it actually has sales

Sirtex Medical is a very promising biotech, I agree... But guess what... Mr Hemming?

First sales for CVac expected in 2012